1. Home
  2. CYCC vs DTI Comparison

CYCC vs DTI Comparison

Compare CYCC & DTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • DTI
  • Stock Information
  • Founded
  • CYCC 1992
  • DTI 1984
  • Country
  • CYCC Malaysia
  • DTI United States
  • Employees
  • CYCC N/A
  • DTI N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • DTI Metal Fabrications
  • Sector
  • CYCC Health Care
  • DTI Industrials
  • Exchange
  • CYCC Nasdaq
  • DTI Nasdaq
  • Market Cap
  • CYCC 61.2M
  • DTI 68.0M
  • IPO Year
  • CYCC N/A
  • DTI N/A
  • Fundamental
  • Price
  • CYCC $1.63
  • DTI $2.62
  • Analyst Decision
  • CYCC
  • DTI Strong Buy
  • Analyst Count
  • CYCC 0
  • DTI 1
  • Target Price
  • CYCC N/A
  • DTI $5.50
  • AVG Volume (30 Days)
  • CYCC 191.0K
  • DTI 56.0K
  • Earning Date
  • CYCC 05-15-2025
  • DTI 05-13-2025
  • Dividend Yield
  • CYCC 147.24%
  • DTI N/A
  • EPS Growth
  • CYCC N/A
  • DTI N/A
  • EPS
  • CYCC N/A
  • DTI N/A
  • Revenue
  • CYCC $14,000.00
  • DTI $160,352,000.00
  • Revenue This Year
  • CYCC $137.21
  • DTI $4.26
  • Revenue Next Year
  • CYCC N/A
  • DTI $6.26
  • P/E Ratio
  • CYCC N/A
  • DTI N/A
  • Revenue Growth
  • CYCC N/A
  • DTI 8.19
  • 52 Week Low
  • CYCC $1.36
  • DTI $1.43
  • 52 Week High
  • CYCC $49.34
  • DTI $6.36
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 32.89
  • DTI 57.72
  • Support Level
  • CYCC $1.36
  • DTI $2.34
  • Resistance Level
  • CYCC $1.94
  • DTI $2.79
  • Average True Range (ATR)
  • CYCC 0.43
  • DTI 0.23
  • MACD
  • CYCC -0.07
  • DTI 0.02
  • Stochastic Oscillator
  • CYCC 8.31
  • DTI 70.69

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.

About DTI Drilling Tools International Corporation

Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.

Share on Social Networks: